The role of TET2 in hematologic neoplasms
- PMID: 21741591
- DOI: 10.1016/j.ccr.2011.06.025
The role of TET2 in hematologic neoplasms
Abstract
TET2 encodes an enzyme that hydroxylates methylcytosine and is frequently targeted by loss-of-function mutations in myelodysplasia, myeloproliferative disorders, and acute myeloid leukemia. In this issue of Cancer Cell, two studies show that inactivation of Tet2 enhances hematopoietic stem cell self renewal and promotes the development of myeloproliferative disorders.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment on
-
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.Cancer Cell. 2011 Jul 12;20(1):11-24. doi: 10.1016/j.ccr.2011.06.001. Epub 2011 Jun 30. Cancer Cell. 2011. PMID: 21723200 Free PMC article.
-
TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.Cancer Cell. 2011 Jul 12;20(1):25-38. doi: 10.1016/j.ccr.2011.06.003. Epub 2011 Jun 30. Cancer Cell. 2011. PMID: 21723201
Publication types
LinkOut - more resources
Molecular Biology Databases